Azenta Inc

$30.20
(as of Jun 17, 11:49 AM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Ticker Information for Azenta Inc

Stock Price
$30.20
Ticker Symbol
AZTA
Exchange
NASDAQ

Industry Information for Azenta Inc

Sector
Healthcare
Industry
Medical Instruments & Supplies

Company Description for Azenta Inc

Country
USA
Full Time Employees
3,000

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in the United States, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates through three reportable segments: Sample Management Solutions, Multiomics, and B Medical Systems. The Sample Management Solutions segment provides sample management products and solutions, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sample repository services. This segment also offers consultation services to clients throughout their experimental design and implementation processes. The Multiomics segment provides genomic and other sample analysis services comprising gene sequencing, synthesis editing, and related services. The B Medical Systems segment manufactures and distributes temperature-controlled storage and transportation solutions to governments, health institutions, and non-government organizations. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.

Fundamentals for Azenta Inc

Market Capitalization
$1,400,864,896
EBITDA
$28,533,000
Dividends per Share
P/E Ratio
Forward P/E Ratio
30.86
Earnings per Share
$-3.27
Earnings per Share Estimate Next Year
Profit Margin
-9.77%
Shares Outstanding
45,779,900
Percent Owned by Insiders
1.79%
Percent Owned by Institutions
116.99%
52-Week High
52-Week Low

Technical Indicators for Azenta Inc

50-Day Moving Average
200-Day Moving Average
RSI
62.29
1.26

Analyst Ratings for Azenta Inc

Strong Buy
1
Buy
1
Hold
5
Sell
0
Strong Sell
0

News About Azenta Inc

Jun 16, 2025, 11:38 PM EST
As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the drug development inputs & services industry, including Fortrea (NASDAQ:FTRE) and its peers. See more.
Jun 16, 2025, 11:34 PM EST
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. See more.
Jun 13, 2025, 12:35 AM EST
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. See more.
Jun 4, 2025, 11:36 PM EST
Let’s dig into the relative performance of Repligen (NASDAQ:RGEN) and its peers as we unravel the now-completed Q1 drug development inputs & services earnings season. See more.